ClinConnect ClinConnect Logo
Search / Trial NCT06663982

Connective Tissue Graft and Leucocyte - Platelet Rich Fibrin in Alveolar Ridge Preservation

Launched by G. D'ANNUNZIO UNIVERSITY · Oct 28, 2024

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying two different methods for preserving the bone and soft tissue in the mouth after a tooth is extracted. The goal is to see which method works better for keeping the area healthy and maintaining the bone structure. One group of participants will receive a treatment that combines a special type of blood product (L-PRF) with a connective tissue graft to help protect the area, while the other group will receive just the L-PRF alone. Researchers will compare how well each method helps in healing and preserving the bone.

To be eligible for this trial, participants need to be over 18 years old and generally healthy, with good oral hygiene. They should have one or more teeth that need to be removed. If you join the study, you can expect to receive one of the two treatments and will be monitored for how well your mouth heals afterward. This trial is not yet recruiting participants, but it aims to gather important information that could help improve dental care after tooth extractions.

Gender

ALL

Eligibility criteria

  • Age \> 18 years old;
  • General good health (ASA I-II);
  • Adequate oral hygiene (Full Mouth Plaque Score ≤ 20%, Full Mouth Bleeding Score ≤ 20%);
  • Presence of one or more hopeless teeth requiring extraction.

About G. D'annunzio University

G. D'Annunzio University, located in Chieti-Pescara, Italy, is a prominent academic institution committed to advancing scientific research and innovation in the health sciences. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages the development of novel therapeutic strategies and clinical applications. As a clinical trial sponsor, G. D'Annunzio University seeks to contribute to the improvement of patient outcomes through rigorous research methodologies, ethical standards, and a focus on translational medicine. Their dedication to education and research excellence positions them as a key player in the advancement of healthcare solutions.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported